Purple biotech to participate at h.c. wainwright 26th annual global investment conference

Rehovot, israel, aug. 30, 2024 (globe newswire) --   purple biotech ltd. ("purple biotech" or "the company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced its executive management will participate in the h.c. wainwright 26th annual global investment conference in a fireside chat presentation (virtual) and one-on-one meetings.
PPBT Ratings Summary
PPBT Quant Ranking